ReviewGene therapy2024

Advancing rare disease treatment: EMA's decade-long insights into engineered adoptive cell therapy for rare cancers and orphan designation.

Maria Elisabeth Kalland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.